Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Akari announces development of its second clinical candidate, votucalis

Feb. 3, 2021

Topline data from pivotal DERMIS-1 and -2 studies of ARQ-151 in plaque psoriasis

Feb. 2, 2021

PF-06826647 is safe and significantly improves disease activity in subjects with plaque psoriasis

Jan. 29, 2021

BirchBioMed reports phase II data on FS-2 for keloid scars

Jan. 25, 2021

Molecularly, skin disease shares much with development

Jan. 25, 2021

Target enrollment complete in diabetic foot ulcer study of SkinTE

Jan. 22, 2021

12-Week study shows benvitimod cream is efficacious and safe in plaque psoriasis

Jan. 21, 2021

Arcutis plans to study roflumilast foam in phase III for seborrheic dermatitis

Jan. 21, 2021

Positive confirmatory data from atopic dermatitis cohort of EDP-1815 phase Ib trial

Jan. 21, 2021

Arcutis initiates pivotal phase III studies of roflumilast cream in patients with atopic dermatitis

Jan. 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...